Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction

NCT02789501 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Catheter Infections
End-stage Renal Disease

Interventions

DEVICE: 4% citrate lock solution regimen
DEVICE: TauroLock lock solution regimen

Sponsor

Medical University of Vienna